NICE Ltd. (NICE) Stock Forecast
NICE analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.07 / 5 from 14 analysts
- Price target
- $132.77 average of analyst targets
- Upside to target
- +18.4% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $2.11
- 52-week range
- $83.15 – $136.90
NICE analyst ratings
14 analystsNumber of analysts at each rating.
NICE price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NICE earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.78 | $2.74 | $2.82 | $3.18 | −12.6% | 13 |
| Current fiscal year (2026) | $11.17 | $11.11 | $11.24 | $12.30 | −9.2% | 14 |
| Next fiscal year (2027) | $12.67 | $11.71 | $13.19 | $11.17 | +13.4% | 14 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NICE revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $785.7M | $784.7M | $787.9M | +7.3% | 12 |
| Current fiscal year (2026) | $3.18B | $3.17B | $3.19B | +8.0% | 14 |
| Next fiscal year (2027) | $3.47B | $3.38B | $3.56B | +9.1% | 14 |
NICE EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NICE revenue: reported and forecast
NICE EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.79 | $2.78 | $2.78 | $2.78 | $2.78 | −0.5% | 3 up · 7 down |
| Current fiscal year (2026) | $11.09 | $11.17 | $11.17 | $11.17 | $11.17 | +0.8% | 0 up · 1 down |
| Next fiscal year (2027) | $12.63 | $12.66 | $12.66 | $12.67 | $12.67 | +0.4% | 9 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NICE earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NICE beat in 11 of 12.
What analysts expect from NICE
14 analysts cover NICE; their consensus rating is buy (4.07 on a 1–5 scale, where 5 is a strong buy). The average price target is $132.77, 18.4% above the latest close of $112.17. Analysts expect earnings of $11.17 per share for 2026, −9.2% from a year earlier. For 2027 the average estimate is $12.67 per share on revenue of $3.5 billion. NICE beat the EPS estimate in 11 of the last 12 quarters.
Related: NICE income statement, NICE key metrics, NICE chart. See the NICE stock overview for the latest quote and news.
NICE forecast FAQ
What is NICE's price target?
The average analyst price target for NICE is $132.77, 18.4% above the latest close of $112.17.
Is NICE a buy, hold or sell?
Of 14 analysts covering NICE, 6 rate it a strong buy, 3 a buy, 5 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is NICE's EPS forecast?
Analysts forecast $11.17 per share for 2026 (range $11.11 to $11.24); for 2027 the estimate is $12.67.
What is NICE's revenue forecast?
The average revenue estimate for 2026 is $3.2 billion, growth of 8.0%; for 2027 it is $3.5 billion.
When does NICE report earnings?
NICE is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 before the market opens; the EPS estimate is $2.11.
Does NICE usually beat earnings estimates?
NICE reported EPS at or above the analyst estimate in 11 of the last 12 quarters.